通裕重工(300185.SZ):公司實際控制權擬發生變更
格隆匯6月29日丨通裕重工(300185.SZ)公佈,公司於2020年6月29日收到了控股股東、實際控制人司興奎擬將其持有的無限售條件流通股8428.43萬股股份(佔公司總股本比例的2.58%)以協議方式轉讓給珠海港集團,並擬將其持有的公司2.53億股股份(佔公司總股本比例的7.74%)的表決權委託給珠海股集團,山東高新投擬將其持有的無限售流通股7910.4萬股份(佔公司總股本比例的2.42%)轉讓給珠海港控股集團有限公司。
本次交易事項最終能否順利實施尚存在不確定性。若本次股份轉讓及表決權委託順利實施完成,公司的控股股東將變更為珠海港集團,實際控制人將變更為珠海市國有資產監督管理委員會。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.